These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37734596)

  • 21. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits.
    Odagiri E; Naruse M; Terasaki K; Yamaguchi N; Jibiki K; Takagi S; Tanabe M; Takano K
    Endocr J; 2004 Jun; 51(3):295-302. PubMed ID: 15256774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Overlooked Disease: Minimal Autonomous Cortisol Secretion (MACS). A Narrative Review.
    Farah S; Nasr L; Eid Fares J
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1518-1524. PubMed ID: 38686896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?
    Vanek C; Loriaux L
    Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):403-405. PubMed ID: 35799460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome.
    Katabami T; Obi R; Shirai N; Naito S; Saito N
    Endocr J; 2005 Aug; 52(4):463-9. PubMed ID: 16127216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.
    Sasaki Y; Katabami T; Asai S; Fukuda H; Tanaka Y
    Endocr J; 2017 Sep; 64(9):833-842. PubMed ID: 28637948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of salivary cortisol in Cushing's syndrome (CS).
    Cardoso EM; Arregger AL; Tumilasci OR; Contreras LN
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):516-21. PubMed ID: 18710466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
    Valassi E; Swearingen B; Lee H; Nachtigall LB; Donoho DA; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4851-9. PubMed ID: 19850679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.
    Tsagarakis S; Vassiliadi D; Thalassinos N
    J Endocrinol Invest; 2006 May; 29(5):471-82. PubMed ID: 16794373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    J Clin Endocrinol Metab; 1998 Feb; 83(2):348-52. PubMed ID: 9467539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone bioavailability: implications for DST research.
    Lowy MT; Meltzer HY
    Biol Psychiatry; 1987 Mar; 22(3):373-85. PubMed ID: 3814685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol-accuracy and pitfalls when screening for Cushing's syndrome.
    Petersenn S
    Pituitary; 2022 Oct; 25(5):693-697. PubMed ID: 35821308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.